Valuation: Divi's Laboratories Limited

Market Cap 2,197B 23.08B 19.97B 18.65B 17.1B 32.17B 32.68B 219B 85.86B 1,101B 86.68B 84.78B 3,640B P/E 2027 *
67.6x
P/E 2028 * 56.1x
Enterprise Value 2,162B 22.71B 19.65B 18.35B 16.83B 31.66B 32.16B 215B 84.49B 1,084B 85.3B 83.43B 3,582B EV / Sales 2027 *
17.2x
EV / Sales 2028 * 14.4x
Free-Float
48%
Yield 2027 *
0.43%
Yield 2028 * 0.46%
1 day-0.89%
1 week+2.72%
Current month+2.72%
1 month+22.20%
3 months+23.46%
6 months+37.36%
Current year+29.45%
1 week 8,105
Extreme 8105
8,585
1 month 6,740.5
Extreme 6740.5
8,585
Current year 5,647.5
Extreme 5647.5
8,585
1 year 5,636.5
Extreme 5636.5
8,585
3 years 3,295.3
Extreme 3295.3
8,585
5 years 2,730
Extreme 2730
8,585
10 years 532.65
Extreme 532.65
8,585
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 48 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap.
26/3/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/3/25 Sell 300 0.0001%
17/2/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.89%+2.72%+34.96%+111.61% 23.08B
-0.52%+3.21%+85.02%+161.12% 1,057B
+0.88%+1.13%+51.13%+49.76% 625B
+0.89%-1.95%+23.73%+63.67% 435B
+0.71%+3.87%+47.45%+38.68% 363B
+0.64%-0.49%+35.39%+40.21% 296B
+0.39%-5.83%+8.64%+9.28% 249B
+1.51%+6.69%+44.34%+62.47% 222B
+3.92%-0.46%-1.21%-44.09% 209B
+1.80%+2.30%+20.79%+65.13% 165B
Average +1.09%+1.05%+35.02%+55.78% 364.39B
Weighted average by Cap. +1.11%+1.23%+48.25%+75.56%

Financials

2027 *2028 *
Net sales 126B 1.32B 1.14B 1.07B 978M 1.84B 1.87B 12.51B 4.91B 62.98B 4.96B 4.85B 208B 150B 1.57B 1.36B 1.27B 1.17B 2.19B 2.23B 14.91B 5.85B 75.06B 5.91B 5.78B 248B
Net income 32.55B 342M 296M 276M 253M 477M 484M 3.24B 1.27B 16.31B 1.28B 1.26B 53.93B 39.3B 413M 357M 334M 306M 575M 585M 3.91B 1.54B 19.7B 1.55B 1.52B 65.11B
Net Debt -35B -368M -318M -297M -273M -513M -521M -3.49B -1.37B -17.54B -1.38B -1.35B -58B -44.85B -471M -408M -381M -349M -657M -667M -4.47B -1.75B -22.48B -1.77B -1.73B -74.32B
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
07/08/26 INR 8,275.00 -0.89% 256,657
06/08/26 INR 8,349.00 -0.46% 327,434
05/08/26 INR 8,388.00 +0.12% 316,801
04/08/26 INR 8,378.00 -2.41% 970,329
03/08/26 INR 8,585.00 +6.57% 1,798,150
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
29
Last Close Price
8,275.00INR
Average target price
8,259.86INR
Spread / Average Target
-0.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock